BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19505981)

  • 1. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
    J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
    Benito B; Nattel S
    J Physiol; 2009 Nov; 587(Pt 21):5011-3. PubMed ID: 19880876
    [No Abstract]   [Full Text] [Related]  

  • 3. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.
    Bacurau AV; Jardim MA; Ferreira JC; Bechara LR; Bueno CR; Alba-Loureiro TC; Negrao CE; Casarini DE; Curi R; Ramires PR; Moriscot AS; Brum PC
    J Appl Physiol (1985); 2009 May; 106(5):1631-40. PubMed ID: 19179649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure.
    Rolim NP; Medeiros A; Rosa KT; Mattos KC; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    Physiol Genomics; 2007 May; 29(3):246-52. PubMed ID: 17244791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
    Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice.
    Medeiros A; Rolim NP; Oliveira RS; Rosa KT; Mattos KC; Casarini DE; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    J Appl Physiol (1985); 2008 Jan; 104(1):103-9. PubMed ID: 17975126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure.
    Ferreira JC; Moreira JB; Campos JC; Pereira MG; Mattos KC; Coelho MA; Brum PC
    Life Sci; 2011 Mar; 88(13-14):578-85. PubMed ID: 21277865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure.
    Medeiros A; Vanzelli AS; Rosa KT; Irigoyen MC; Brum PC
    Braz J Med Biol Res; 2008 Sep; 41(9):812-7. PubMed ID: 18820772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice.
    Pereira MG; Ferreira JC; Bueno CR; Mattos KC; Rosa KT; Irigoyen MC; Oliveira EM; Krieger JE; Brum PC
    Eur J Appl Physiol; 2009 Apr; 105(6):843-50. PubMed ID: 19125280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
    Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
    Zhang Q; Qi H; Cao Y; Shi P; Song C; Ba L; Chen Y; Gao J; Li S; Li B; Sun H
    J Cell Mol Med; 2018 Dec; 22(12):6055-6067. PubMed ID: 30299584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
    Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
    Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.
    Walther S; Awad S; Lonchyna VA; Blatter LA
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H856-66. PubMed ID: 24441548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.
    Tang M; Li J; Huang W; Su H; Liang Q; Tian Z; Horak KM; Molkentin JD; Wang X
    Cardiovasc Res; 2010 Dec; 88(3):424-33. PubMed ID: 20601385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.